Immunotherapy Plus Chemoradiotherapy Triples Survival in Esophageal Cancer Study
A propensity score matched study from Taiwan finds that adding the immunotherapy drug nivolumab to definitive chemoradiotherapy tripled median overall ...
A propensity score matched study from Taiwan finds that adding the immunotherapy drug nivolumab to definitive chemoradiotherapy tripled median overall ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine